From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systems.

If Europe's health systems make a conscious decision to increase their utilization of technology and techniques that can enhance prevention and expedite early-stage diagnosis, they can effectively address the growing challenges of disease. By embracing these advancements, these health systems can significantly improve their response to emerging health issues.However, at present the effective integration and exploitation of these opportunities remains hesitant and suboptimal, and health and health services underperform accordingly, with patients suffering from the continuing variations in diagnosis and access to innovation. This paper presents a comprehensive study that examines the current state of various influential disciplines and factors in European countries. It specifically focuses on the adoption of Next Generation Screening technologies and the development stage of Public Health Genomics. The assessment of these areas is presented in the context of a rapidly changing policy environment, which provides an opportunity for a fundamental reconsideration of how and where new tools can be integrated into healthcare systems and routine practices. Top of Form [Display omitted] • NGS Adoption: European nations differ in NGS tech adoption, with disparities between leaders and laggards. • Policy Impact: Strong policies enhance NGS tech integration in healthcare. • Collaboration: Unified data standards, legal frameworks, and training are essential for Europe-wide NGS integration. • Benefits: NGS integration improves healthcare services, research, diagnostics, and treatments. • Conditions: Progress requires better workforce capacity, data sharing, collaboration, and policy leadership. [ABSTRACT FROM AUTHOR]